Quercetin improves lipid metabolism via SCAP-SREBP2-LDLr signaling pathway in early stage diabetic nephropathy

References

• Guariguata L , Whiting DR , Hambleton I , Beagleya J , Linnenkampa U , Shaw JE . Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract . 2014;103(2):137–149. doi:10.1016/j.diabres.2013.11.002 24630390
   PubMed Web of Science ®Google Scholar
• Figueroa-Pérez MG , Pérez-Ramírez IF , Enciso-Moreno JA , Gallegos-Corona MA , Salgado LM , Reynoso-Camacho R . Diabetic nephropathy is ameliorated with peppermint (Mentha piperita) infusions prepared from salicylic acid-elicited plants. J Funct Foods . 2018;43:55–61. doi:10.1016/j.jff.2018.01.029
   Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet . 1998;352(9131):837–853.9742976
   PubMed Web of Science ®Google Scholar
• Khangholi S , Majid FA , Berwary NJ , Ahmad F , Aziz RB . The mechanisms of inhibition of advanced glycation end products formation through polyphenols in hyperglycemic condition. Planta Med . 2016;82(1–2):32–45. doi:10.1055/s-0035-1558086 26550791
   PubMed Web of Science ®Google Scholar
• Tsai SF , Su CW , Wu MJ , et al. Urinary cyclophilin A as a new marker for diabetic nephropathy: a cross-sectional analysis of diabetes mellitus. Medicine . 2015;94(42):e1802. doi:10.1097/MD.0000000000000874 26496315
   PubMed Web of Science ®Google Scholar
• Zhang Y , Ma KL , Liu J , et al. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy. Acta Diabetol . 2015;52(6):1045–1056. doi:10.1007/s00592-015-0753-9 25896009
   PubMed Web of Science ®Google Scholar
• Mount P , Davies M , Choy S-W , Cook N , Power D . Obesity-related chronic kidney disease – the role of lipid metabolism. Metabolites . 2015;5(4):720–732. doi:10.3390/metabo5040720 26690487
   PubMedGoogle Scholar
• Yuan Y , Sun H , Sun ZL . Advanced glycation end products (AGEs) increase renal lipid accumulation: apathogenic factor of diabetic nephropathy (DN). Lipids Health Dis . 2017;16(1):126. doi:10.1186/s12944-017-0565-8 28659153
   PubMed Web of Science ®Google Scholar
• Herman-Edelstein M , Scherzer P , Tobar A , Levi M , Gafter U . Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res . 2014;55(3):561–572. doi:10.1194/jlr.P040501 24371263
   PubMed Web of Science ®Google Scholar
• Allen TJ , Cooper ME , Lan HY . Use of genetic mouse models in the study of diabetic nephropathy. Curr Diab Rep . 2004;4(6):435–440.15539008
   PubMedGoogle Scholar
• de Boer IH . A new chapter for diabetic kidney disease. N Engl J Med . 2017;377(9):885–887. doi:10.1056/NEJMe1708949 28854097
   PubMed Web of Science ®Google Scholar
• D’Addio F , Trevisani A , Ben Nasr M , et al. Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy. Acta Diabetol . 2014;51(6):897–904. doi:10.1007/s00592-014-0603-1 24894496
   PubMed Web of Science ®Google Scholar
• Rice LM , Donigan M , Yang M , et al. Protein phosphatase 2A (PP2A) regulates low density lipoprotein uptake through regulating sterol response element-binding protein-2 (SREBP-2) DNA binding. J Biol Chem . 2014;289(24):17268–17279. doi:10.1074/jbc.M114.570390 24770487
   PubMed Web of Science ®Google Scholar
• Vallett SM , Sanchez HB , Rosenfeld JM , Osborne TF . A direct role for sterol regulatory element binding protein in activation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene. J Biol Chem . 1996;271(21):12247–12253.8647822
   PubMed Web of Science ®Google Scholar
• Brown MS , Goldstein JL . A receptor-mediated pathway for cholesterol homeostasis (Nobel lecture). Angew Chem Int Ed . 1986;17(45):34–47.
   Google Scholar
• Sun H , Yuan Y , Sun Z-L . Cholesterol contributes to diabetic nephropathy through SCAP- SREBP-2 pathway. Int J Endocrinol . 2013;2013:1–8. doi:10.1155/2013/592576
   Web of Science ®Google Scholar
• Sun GD , Li CY , Cui WP , et al. Review of herbal traditional Chinese medicine for the treatment of diabetic nephropathy. J Diabetes Res . 2016;2016:1–18.
   Web of Science ®Google Scholar
• Wen X , Zeng Y , Liu L , et al. Zhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1c. J Ethnopharmacol . 2012;142(1):144–150. doi:10.1016/j.jep.2012.04.028 22564814
   PubMed Web of Science ®Google Scholar
• D’Andrea G . Quercetin: a flavonol with multifaceted therapeutic applications? Fitoterapia . 2015;106:256–271. doi:10.1016/j.fitote.2015.09.018 26393898
   PubMed Web of Science ®Google Scholar
• Khan F , Niaz K , Maqbool F , et al. Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients . 2016;8(9):529. doi:10.3390/nu8090529
   PubMed Web of Science ®Google Scholar
• Miltonprabu S , Tomczyk M , Skalicka-Woźniak K , et al. Hepatoprotective effect of quercetin: from chemistry to medicine. Food Chem Toxicol . 2017;108(Part B):365–374. doi:10.1016/j.fct.2016.08.034 27591927
   PubMed Web of Science ®Google Scholar
• Li XL , Zhou N , Wang J , et al. Quercetin suppresses breast cancer stem cells (CD44+/CD24−) by inhibiting the PI3K/Akt/mTOR-signaling pathway. Life Sci . 2018;196:56–62. doi:10.1016/j.lfs.2018.01.014 29355544
   PubMed Web of Science ®Google Scholar
• Peng J , Li Q , Li K , et al. Quercetin improves glucose and lipid metabolism of diabetic rats: involvement of Akt signaling and SIRT1. J Diabetes Res . 2017;2017:1–10. doi:10.1155/2017/3417306
   Web of Science ®Google Scholar
• Jeong S-M , Kang M-J , Choi H-N , Kim J-H , Kim J-I . Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr Res Pract . 2012;6(3):201–207. doi:10.4162/nrp.2012.6.3.201 22808343
   PubMed Web of Science ®Google Scholar
• Guo XP , Chen M , Zeng HM , et al. Quercetin attenuates ethanol-inducediron uptake and myocardial injury by regulating the angiotensin II-L-type calcium channel. Mol Nutr Food Res . 2018;62:1700772. doi:10.1002/mnfr.201700879
   Web of Science ®Google Scholar
• Yuan YY , Ge SN , Lv ZH , et al. Attenuation of perfluorooctanoic acid-induced testicular oxidative stress and apoptosis by quercetin in mice. RSC Adv . 2017;7:45045–45052. doi:10.1039/C7RA09036F
   Web of Science ®Google Scholar
• Zhou L , An X-F , Teng S-C , et al. Pretreatment with the total flavone glycosides of flos abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy. J Med Food . 2012;15(5):461–468. doi:10.1089/jmf.2011.1921 22439874
   PubMed Web of Science ®Google Scholar
• Ge J , Miao J-J , Sun X-Y , Yu J-Y . Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats. J Ethnopharmacol . 2016;189:238–249. doi:10.1016/j.jep.2016.05.033 27224243
   PubMed Web of Science ®Google Scholar
• Bindesbøll C , Berg O , Arntsen B , Nebb HI , Dalen KT . Fatty acids regulate perilipin5 in muscle by activating PPARδ. J Lipid Res . 2013;54(7):1949–1963. doi:10.1194/jlr.M038992 23606724
   PubMed Web of Science ®Google Scholar
• Dong J , Zhang X , Zhang L , et al. Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: amechanism including AMPKα1/SIRT1. J Lipid Res . 2014;55:363–374. doi:10.1194/jlr.M038786 24465016
   PubMed Web of Science ®Google Scholar
• Harwood M , Danielewskanikiel B , Borzelleca JF , Flamm GW , Williams GM , Lines TC . A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol . 2007;45(11):2179–2205. doi:10.1016/j.fct.2007.05.015 17698276
   PubMed Web of Science ®Google Scholar
• Lv M , Chen Z , Hu G , Li Q . Therapeutic strategies of diabetic nephropathy: recentprogress and future perspectives. Drug Discov Today . 2015;20(3):332–346. doi:10.1016/j.drudis.2014.10.007 25448752
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care . 2010;33(Suppl 1):S11–S61. doi:10.2337/dc10-S011 20042772
   PubMed Web of Science ®Google Scholar
• Lu Q , Ji X-J , Zhou Y-X , et al. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy. Pharmacol Res . 2015;99:237–247. doi:10.1016/j.phrs.2015.06.006 26151815
   PubMed Web of Science ®Google Scholar
• Lai P-B , Zhang L , Yang L-Y . Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats. Ren Fail . 2012;34(1):83–87. doi:10.3109/0886022X.2011.623564 22011322
   PubMed Web of Science ®Google Scholar
• Debendra NR , Islam MD , Biswas M , Sana S , Debendra S , Roy N . Dyslipidemia in diabetes patient is responsible for developing nephritic syndrome with increasing ages, a survey based cross sectional study. Int J Biomed Res . 2016;7:652–657.
   Google Scholar
• Tangvarasittichai S . Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes . 2015;6(3):456–480. doi:10.4239/wjd.v6.i3.456 25897356
   PubMed Web of Science ®Google Scholar
• Nekohashi M , Ogawa M , Ogihara T , et al. Luteolin and quercetin affect the cholesterol absorption mediated by epithelial cholesterol transporter niemann-pick C1-like 1 in Caco-2 cells and rats. PLoS One . 2014;9(5):e97901. doi:10.1371/journal.pone.0097901 24859282
   PubMed Web of Science ®Google Scholar
• Quiroga B , Arroyo D , de Arriba G . Present and future in the treatment of diabetic kidney disease. J Diabetes Res . 2015;2015:801348. doi:10.1155/2015/815839 25945357
   PubMed Web of Science ®Google Scholar
• Shaikh AS , Somani RS . Animal models and biomarkers of neuropathy in diabetic rodents. Indian J Pharmacol . 2010;42(3):129–134. doi:10.4103/0253-7613.66833 20871761
   PubMed Web of Science ®Google Scholar
• Zhang J , Wang Y , Gurung P , et al. The relationship between the thickness of glomerular basement membrane and renal outcomes in patients with diabetic nephropathy. Acta Diabetol . 2018;55(7):669–679. doi:10.1007/s00592-018-1128-9 29610978
   PubMed Web of Science ®Google Scholar
• Hu Q-H , Zhang X , Pan Y , Li Y-C , Kong L-D . Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats. Biochem Pharmacol . 2012;84(1):113–125. doi:10.1016/j.bcp.2012.03.005 22426011
   PubMed Web of Science ®Google Scholar
• Rivera L , Morón R , Sánchez M , Zarzuelo A , Galisteo M . Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity . 2008;16(9):2081–2087. doi:10.1038/oby.2008.315 18551111
   PubMed Web of Science ®Google Scholar
• Wang XX , Jiang T , Shen Y , et al. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes . 2010;59(11):2916–2927. doi:10.2337/db10-0019 20699418
   PubMed Web of Science ®Google Scholar
• Pisonero-Vaquero S , Martínez Ferreras Á , García-Mediavilla M , et al. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease. Mol Nutr Food Res . 2015;59(5):879–893. doi:10.1002/mnfr.201400913 25712622
   PubMed Web of Science ®Google Scholar
• Cai X , Bao L , Dai X , Ding Y , Zhang Z , Li Y . Quercetin protects RAW264.7 macrophages from glucosamine-induced apoptosis and lipid accumulation via the endoplasmic reticulum stress pathway. Mol Med Rep . 2015;12(5):7545–7553. doi:10.3892/mmr.2015.4340 26398703
   PubMed Web of Science ®Google Scholar
• Seiva FR , Chuffa LG , Braga CP , Amorima JP , Fernandes AA . Quercetin ameliorates glucose and lipid metabolism and improves antioxidant status in postnatally monosodium glutamate-induced metabolic alterations. Food Chem Toxicol . 2012;50(10):3556–3561. doi:10.1016/j.fct.2012.07.009 22809473
   PubMed Web of Science ®Google Scholar
• Wang Z , Jiang T , Li J , et al. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes . 2005;54(8):2328–2335.16046298
   PubMed Web of Science ®Google Scholar
• Istvan ES , Deisenhofer J . Structural mechanism for statin inhibition of HMG-CoA reductase. Science . 2001;292(5519):1160–1164. doi:10.1126/science.1059344 11349148
   PubMed Web of Science ®Google Scholar
• Moon Y-A , Liang GS , Xie XF , et al. The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab . 2012;15(2):240–246. doi:10.1016/j.cmet.2011.12.017 22326225
   PubMed Web of Science ®Google Scholar